News
In particular, Aradhye noted "increasing progress" at all levels of the innovation supply chain in China — "whether it's ...
British pharmaceutical giant GSK committed to investing at least $30 billion in U.S. research and developing and ...
Structurally-guided discovery using high-resolution cryo-EM has delivered potent, DCAF16-dependent Targeted Glues™ of SMARCA2, with exquisite ...
13hon MSN
GSK adding a biologics factory in Upper Merion as part of a $1.2 billion investment in the U.S.
The new projects, including AI efforts in Pennsylvania and three other states, are part of the British firm's pledge to ...
DelveInsight's Interleukin-13 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report ...
The British drugmaker’s commitment comes just as some of its pharma peers question their presence in the U.K. amid a widening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback